Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Sales | 2 | 2 | 4 | 3 | 1 |
Gross Profit | 2 | 2 | 4 | 3 | 1 |
Operating Expenses | 8,747 | 8,795 | 7,891 | 6,001 | 7,208 |
Operating Income | -8,745 | -8,793 | -7,887 | -5,998 | -7,207 |
Pre-tax Income | -8,745 | -8,793 | -7,887 | -5,998 | -7,207 |
Net Income Continuous | -8,745 | -8,793 | -7,887 | -5,998 | -7,207 |
Net Income | $-8,745 | $-8,793 | $-7,887 | $-5,998 | $-7,207 |
EPS Basic Total Ops | -0.38 | -0.38 | -0.32 | -0.26 | -0.38 |
EPS Basic Continuous Ops | -0.38 | -0.38 | -0.32 | -0.26 | -0.38 |
EPS Diluted Total Ops | -0.38 | -0.38 | -0.32 | -0.26 | -0.38 |
EPS Diluted Continuous Ops | -0.38 | -0.38 | -0.32 | -0.26 | -0.38 |
EBITDA(a) | $-8,733 | $-8,782 | $-8,024 | $-5,936 | $-7,145 |